Xencor Inc — Director's Dealing 2018

Sep 18, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Xencor Inc (XNCR)
CIK: 0001326732
Period of Report: 2018-09-17

Reporting Person: Foster Paul A (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-09-17	Common Stock	M	40000	$11.05	Acquired	44952	Direct
2018-09-17	Common Stock	S	40000	$46.0302	Disposed	4952	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-09-17	Stock Option (right to buy)	$11.05	M	40000	Disposed	2024-02-20	Common Stock (40000)	Direct

Footnotes

F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted August 17, 2018.

F2: The weighted average sale price for the transaction reported was $46.0302, and the range of prices were between $46.0121 and $46.0782. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.

F3: The stock option is fully vested.